Secondary Logo

Journal Logo

1995 - Volume 15 - Issue 4
pp: 275-369

PDF Only



PDF Only



PDF Only



PDF Only


Phase II Dose-Ranging Trial of Foscarnet Salvage Therapy for Cytomegalovirus Retinitis in AIDS Patients Intolerant of or Resistant to Ganciclovir (ACTG Protocol 093): AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

Jacobson, M A; Wulfsohn, M; Feinberg, J E; More

Retina. 15(4):364, 1995.


PDF Only


Show: